Brand dynamics
Group Real-Time Dynamics And Cutting-Edge Information In The Field Of One Health
Time Posted：2022-06-13 18:26
On the evening of June 10, Healthy Yuan (600380.SH) announced that it had recently received the Drug Registration Certificate issued by the National Medical Products Administration for its independently developed terbutaline sulfate nebulization solution. The acceptance number is CYHS2100104.
Time Posted：2022-06-13 15:26
On the morning of June 10, the 14th China Bioindustry Convention opened on Guangzhou International Bio Island. At the high-level forum, Zhong Nanshan, chairman of the conference, recipient of the "Medal of the Republic," and academician of the Chinese Academy of Engineering, delivered a keynote speech entitled "Fighting the Epidemic with Science and Technology—Preventing the Epidemic, Stabilizing the Economy," exploring hot issues and development trends in global public health, human health, and strengthening the national biosafety risk prevention and control and governance system. Academician Zhong also reviewed the representative COVID-19 vaccines and therapeutic drugs in China that participated in the cooperation signing ceremony.
Time Posted：2022-06-13 15:22
Guangzhou, June 11 (Reporter Xia Yan) On June 10, the 14th China Bioindustry Convention High-Level Forum opened in Guangzhou. Zhong Nanshan, an academician of the Chinese Academy of Engineering, delivered a keynote speech entitled "Fighting the Epidemic with Science and Technology - Preventing the Epidemic, Stabilizing the Economy", suggesting the use of heterologous vaccines for sequential vaccination.
Lizhu Reagent's monkeypox virus detection product obtains CE certification
Time Posted：2022-06-10 22:23
According to a WHO report on June 8, within a month (May 13 to June 8), more than 1000 confirmed cases of monkeypox have been reported to WHO from 29 countries and regions where monkeypox is not endemic. Since the first confirmed case of monkeypox was reported in the UK in early May, the monkeypox virus has spread rapidly in non-endemic countries and regions, with Europe being the hardest hit. In response to the sudden global outbreak of monkeypox, Lizhu Reagent responded quickly and actively developed a monkeypox virus nucleic acid detection kit (PCR-fluorescence probe method), which has obtained EU CE approval.
Time Posted：2022-06-02 19:16
On the evening of June 1, Healthy Yuan (600380.SH) announced that its holding subsidiary, Lizhu Pharmaceutical Group Co., Ltd.'s wholly-owned subsidiary, Lizhu Pharmaceutical Factory (hereinafter referred to as "Lizhu Pharmaceutical Factory"), received the "Drug Supplement Application Approval Notice" issued by the National Medical Products Administration. The Valsartan Capsules produced by Lizhu Pharmaceutical Factory have passed the consistency evaluation of quality and efficacy of generic drugs.
Time Posted：2022-05-27 18:00
Currently, the company's respiratory inhalation preparation sector has four products (seven specifications) approved for marketing, including levalbuterol hydrochloride nebulization solution, combined ipratropium bromide inhalation solution, ipratropium bromide inhalation solution, and budesonide suspension for inhalation. Among them, levalbuterol hydrochloride nebulization solution has been included in the national medical insurance catalog, and after the implementation of medical insurance in March 2021, it has achieved rapid coverage and sales growth; the other three products have been successfully selected for the fifth batch of national centralized procurement, with significant volume increase and accelerated commercialization.
Time Posted：2022-05-20 10:53
Among the top ten pharmaceutical companies in R&D investment, two major listed companies under HealthGen Biotech Group, HealthGen and Lizhu Pharmaceutical, had R&D expenses of 1.397 billion yuan and 1.146 billion yuan respectively in 2021, representing a year-on-year increase of 30.36% and 29.59%, ranking sixth and seventh on the list respectively. In the face of a complex and changing market environment, HealthGen adheres to R&D innovation as its driving force, focusing on patient needs and innovative drugs and high-barrier complex preparations. Building on its existing advantages in inhalation administration, sustained-release microspheres, and antibody technologies, HealthGen is developing a new complex injection technology platform represented by micro-nano injections, marking a new stage in product structure optimization and adjustment.
Time Posted：2022-05-13 17:19
The Guangdong Trademark Association has announced the "2021 List of Key Trademarks for Protection in Guangdong Province." After review and approval by the Guangdong Trademark Association's Key Trademark Protection Committee, 607 trademarks, including "太太, 静心, 鹰牌, QQ, 百度, 广汽", have been included in the list. Three trademarks under Jiankangyuan Pharmaceutical Group, namely "太太", "静心", and "鹰牌", stood out among the 1287 trademarks submitted for expert review.
Quick Navigation
+86 755-33268688 | Service Hotline
Official WeChat Official Account
Copyright © 2025 Joincare Pharmaceutical Group Industry Co., Ltd. ALL Rights Reserve.